血管外科学会关于间歇性跛行管理的适宜使用标准
血管外科学会采用RAND适宜性方法,结合最佳证据与专家意见制定间歇性跛行管理适宜使用标准(AUC)。第二轮评级覆盖主髂、股总及股腘段2280个场景,仅9个(0.4%)出现分歧。核心原则包括:运动疗法为所有患者首选初始管理;股总段开放内膜剥脱术净获益大于腔内干预;膝下段干预获益不明确且可能有害。
要点
- 运动疗法是所有间歇性跛行患者首选的初始管理策略。
- 未完成运动疗法的特定患者,有创治疗可能提供净获益。
- 股总段开放内膜剥脱术净获益大于腔内干预。
核心结论
- 这些适宜使用标准为个体化医患共享决策提供框架,并非绝对要求或禁止。
- 对于评级不确定的场景,应结合临床判断与最佳证据决定治疗策略。
- 适宜使用标准应定期重新评估以保持相关性。
研究设计与样本
- 采用RAND适宜性方法,结合医学文献最佳证据与专家意见,使用改良德尔菲流程制定。
- 第二轮评级对主髂、股总及股腘段间歇性跛行治疗的2280个独特场景进行评分。
主要发现
- 2280个场景中仅9个(0.4%)使用对称调整百分位间范围公式显示分歧,表明专家组共识度极高。
- 事后将「不适宜」替换为「风险大于获益」,将「适宜」替换为「获益大于风险」。
关键数值与推荐
- 运动疗法是所有间歇性跛行患者首选的初始管理策略。
- 对于未完成运动疗法的患者,若为非吸烟者、接受最佳药物治疗、生理和技术风险低、生活方式严重受限和/或步行距离短,有创治疗可能提供净获益。
- 鉴于现有技术的长期耐久性,股腘段有创干预应保留给生活方式严重受限且步行距离短的患者。
- 在股总段,开放股总动脉内膜剥脱术治疗间歇性跛行的净获益大于腔内干预。
- 在膝下段,有创干预治疗间歇性跛行的获益不明确且可能有害。
临床怎么用
- 适宜使用标准不应被解释为对评级为适宜(获益大于风险)的治疗的要求。
- 适宜使用标准不应被解释为对评级为不适宜(风险大于获益)的治疗的禁止。
- 临床情况中可能出现未纳入这些适宜使用标准的调节因素,会改变个体患者治疗的适宜性水平。
- 正确实施适宜使用标准需要描述那些调节患者因素。
- 对于评级不确定的场景,需要机制来追踪治疗决策和结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Society for Vascular Surgery appropriate use criteria (AUC) for the management of intermittent claudication were created using the RAND appropriateness method, a validated and standardized method that combines the best available evidence from medical literature with expert opinion, using a modified Delphi process. These criteria serve as a framework on which individualized patient and clinician shared decision-making can grow. These criteria are not absolute. AUC should not be interpreted as a requirement to administer treatments rated as appropriate (benefit outweighs risk). Nor should AUC be interpreted as a prohibition of treatments rated as inappropriate (risk outweighs benefit). Clinical situations will occur in which moderating factors, not included in these AUC, will shift the appropriateness level of a treatment for an individual patient. Proper implementation of AUC requires a description of those moderating patient factors. For scenarios with an indeterminate rating, clinician judgement combined with the best available evidence should determine the treatment strategy. These scenarios require mechanisms to track the treatment decisions and outcomes. AUC should be revisited periodically to ensure that they remain relevant. The panelists rated 2280 unique scenarios for the treatment of intermittent claudication (IC) in the aortoiliac, common femoral, and femoropopliteal segments in the round 2 rating. Of these, only nine (0.4%) showed a disagreement using the interpercentile range adjusted for symmetry formula, indicating an exceptionally high degree of consensus among the panelists. Post hoc, the term "inappropriate" was replaced with the phrase "risk outweighs benefit." The term "appropriate" was also replaced with "benefit outweighs risk." The key principles for the management of IC reflected within these AUC are as follows. First, exercise therapy is the preferred initial management strategy for all patients with IC. Second, for patients who have not completed exercise therapy, invasive therapy might provide net a benefit for selected patients with IC who are nonsmokers, are taking optimal medical therapy, are considered to have a low physiologic and technical risk, and who are experiencing severe lifestyle limitations and/or a short walking distance. Third, considering the long-term durability of the currently available technology, invasive interventions for femoropopliteal disease should be reserved for patients with severe lifestyle limitations and a short walking distance. Fourth, in the common femoral segment, open common femoral endarterectomy will provide greater net benefit than endovascular intervention for the treatment of IC. Finally, in the infrapopliteal segment, invasive intervention for the treatment of IC is of unclear benefit and could be harmful.
引用
- Woo K, Siracuse JJ, Klingbeil K, et al. Society for Vascular Surgery appropriate use criteria for management of intermittent claudication. J Vasc Surg. 2022. PMID: 35470016. doi:10.1016/j.jvs.2022.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。